Medifast (MED) Operating Leases (2019 - 2026)

Medifast has reported Operating Leases for 8 years, with the latest figure at $12.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 16.63% year-over-year to $12.2 million; the trailing twelve-month figure through Mar 2026 stood at $12.2 million (down 16.63% YoY), and the FY2025 full-year result was $6.1 million, down 38.74% from the prior year.
• Operating Leases for Q1 2026 stood at $12.2 million, up from $6.1 million in the prior quarter.
• The five-year high for Operating Leases was $29.3 million in Q2 2022, with the low at $6.1 million in Q4 2025.
• Historically, Operating Leases has averaged $16.7 million across 5 years, with a median of $16.1 million in 2023.
• Annual changes were most pronounced in 2022 — Operating Leases jumped 269.21% — and 2024, when it tumbled 48.45%.
• Medifast's Operating Leases stood at $20.3 million in 2022, then dropped by 20.46% to $16.1 million in 2023, then plunged by 38.35% to $9.9 million in 2024, then sank by 38.74% to $6.1 million in 2025, then soared by 99.98% to $12.2 million in 2026.
• The last three Operating Leases figures came in at $12.2 million (Q1 2026), $6.1 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.